Agios Pharmaceuticals (AGIO) Return on Sales (2016 - 2025)
Historic Return on Sales for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q3 2025 value amounting to 8.03%.
- Agios Pharmaceuticals' Return on Sales fell 1137800.0% to 8.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.0%, marking a year-over-year decrease of 294100.0%. This contributed to the annual value of 18.46% for FY2024, which is N/A changed from last year.
- Per Agios Pharmaceuticals' latest filing, its Return on Sales stood at 8.03% for Q3 2025, which was down 1137800.0% from 9.04% recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Return on Sales ranged from a high of 105.75% in Q3 2024 and a low of 14.71% during Q1 2023
- Over the past 5 years, Agios Pharmaceuticals' median Return on Sales value was 9.0% (recorded in 2024), while the average stood at 4.43%.
- In the last 5 years, Agios Pharmaceuticals' Return on Sales surged by 1180900bps in 2024 and then plummeted by -1137800bps in 2025.
- Quarter analysis of 5 years shows Agios Pharmaceuticals' Return on Sales stood at 44.14% in 2021, then crashed by -99bps to 0.4% in 2022, then plummeted by -3490bps to 13.51% in 2023, then soared by 33bps to 9.0% in 2024, then grew by 11bps to 8.03% in 2025.
- Its last three reported values are 8.03% in Q3 2025, 9.04% for Q2 2025, and 10.38% during Q1 2025.